US2011160278A1PendingUtilityA1
Methods For Selectively Modulating Survivin Apoptosis Pathways
Est. expiryFeb 29, 2020(expired)· nominal 20-yr term from priority
Inventors:Dario C. Altieri
C07K 16/18G01N 33/5011A61P 43/00C12Q 1/485A61P 35/00G01N 2500/00
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention, based on the discovery of a new biological phenomena, provides methods and compositions for use in identifying agents that modulate the phosphorylation of survivin, the interaction between survivin and p34 cdc2 -cyclin B1 kinase complex, and the interaction between survivin and caspase-9. Related methods and compositions can be used to modulate survivin regulated apoptosis.
Claims
exact text as granted — not AI-modified1 - 29 . (canceled)
30 . A method of inhibiting the growth of a tumor cell comprising administering an effective amount of an antisense survivin nucleic acid to the tumor cell.
31 . The method of claim 30 , wherein the tumor cell is in a tumor mass.
32 . The method of claim 31 , wherein the tumor mass is present in a mammal.
33 . The method of claim 32 , wherein the tumor mass is a melanoma.
34 . The method of claim 31 , wherein the method inhibits the growth of a tumor mass in vivo.
35 . The method of claim 30 , wherein the method inhibits the growth of a tumor cell in vitro.
36 . The method of claim 30 , wherein the method inhibits the growth of a tumor cell is in vivo.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.